"Designing Growth Strategies is in our DNA"

U.S. Mycoplasma Testing Market Size, Share & COVID-19 Impact Analysis, By Product (Instruments and Reagents & Kits), By Testing Method (PCR-based, Culture-based, and Others), By Application (Cell Culture, Vaccine Testing, Virus Testing, and Others), and By End-user (Biopharmaceutical & Biotechnology Companies, Cell Banks, Contract Research & Contract Manufacturing Organizations, and Others), and Country Forecast, 2023-2030

Last Updated: March 10, 2025 | Format: PDF | Report ID: FBI108747

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Overview of R&D Expenditure, U.S., 2022
    2. Technological Advancements in Mycoplasma Testing
    3. Key Industry Developments – Mergers, Acquisitions & Partnership
    4. New Product Launches
    5. Impact of COVID-19 on the Market
  5. U.S. Mycoplasma Testing Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Testing Method
      1. PCR-based
      2. Culture-based
      3. Others
    2. Market Analysis, Insights and Forecast – By Product
      1. Instruments
      2. Reagents & Kits
    3. Market Analysis, Insights and Forecast – By Application
      1. Cell Culture
      2. Vaccine Testing
      3. Virus Testing
      4. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Biopharmaceutical & Biotechnology Companies
      2. Cell banks
      3. Contract Research Organizations & Contract Manufacturing Organizations
      4. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Merck KGaA
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Thermo Fisher Scientific Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Sartorius AG
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Asahi Kasei Corporation
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. BIOMÉRIEUX
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Charles River Laboratories
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. ATCC
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Other Prominent Players
Read Less

Figure 1:  U.S. Mycoplasma Testing Market Revenue Breakdown (USD million, %) by Testing Method, 2022 & 2030

Figure 2: U.S. Mycoplasma Testing Market Value Share (%), by Testing Method, 2022 & 2030

Figure 3:  U.S. Mycoplasma Testing Market Value Share (%), by Product, 2022 & 2030

Figure 4:  U.S. Mycoplasma Testing Market Value Share (%), by Application, 2022 & 2030

Figure 5:  U.S. Mycoplasma Testing Market Value Share (%), by End User, 2022 & 2030

Figure 6:  U.S. Mycoplasma Testing Market Share (%), By Company, 2022

Table 1:  U.S. Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2019-2030

Table 2:  U.S. Mycoplasma Testing Market Revenue (USD million) Forecast, by Product, 2019-2030

Table 3:  U.S. Mycoplasma Testing Market Revenue (USD million) Forecast, Application, 2019-2030

Table 4:  U.S. Mycoplasma Testing Market Revenue (USD million) Forecast, End User, 2019-2030

  • 2019-2030
  • 2022
  • 2019-2021
  • 80
Consulting Services
    How will you benefit from our consulting services ?